AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 201 min read$HTFL

Farquhar John C.M. sold $1.5M of HTFL

Farquhar John C.M. (Chief Executive Officer) sold 32,676 shares of Heartflow, Inc. (HTFL) at $45.00 ($1.47M total) on 2026-08-18 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Farquhar John C.M.
Published Aug 20, 2026, 9:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$HTFL
Bearish
medium confidence
Mentioned
$HTFL
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HTFLBearishLow
01

Why it matters

The CEO's sale may prompt short‑term selling pressure but likely limited impact given the pre‑arranged nature of the trade.

02

Market read

Primary insider sale provides new, material information for traders; modest relevance.

03

What to watch

Potential upcoming dilution or secondary offering not disclosed.

Relevance 5/10Novelty 6/10Timing: post‑market 2026‑08‑18

Background

Form 4 filing discloses insider transactions; investors monitor such sales for cues.

Company-level read

Ticker impact

$HTFLBearishMedium confidence
Context

CEO Farquhar sold 32,676 shares for $1.47M via a 10b5‑1 plan on 2026‑08‑18.

Expected impact

Potential short‑term dip of 1‑2% as market digests the sale.

Evidence & confidence

Sale size is material for a mid‑cap but not large enough to drive a major move; CEO's use of a pre‑arranged plan limits interpretive weight.

Market effects

Sector

Minimal impact on the cardiovascular device sector; no broader industry signal.

Regional

US market only; no regional ripple.

Global

Low global relevance.

Counterpoint

What could challenge this read

The sale could be purely liquidity‑driven and not reflect company outlook.

Key entities

  • Company
    Heartflow, Inc.

    Medical device company listed on NASDAQ.

  • Executive
    John C.M. Farquhar

    Chief Executive Officer of Heartflow.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

HTFL insider trading history →

Related articles

SEP 13
$HTFLHigh

HTFL Soars After Q2 Beat And Raised 2026 Revenue Outlook

HeartFlow (HTFL) stock rose 9.63% after Q2 earnings beat and raised 2026 revenue outlook. Q2 revenue was $64.08M with 80.1% gross margin, but -55.8% profit margin. Company has strong liquidity with $162.55M cash and low debt. Analysts see near-term support at $46-$47 and resistance at $54-$56, with a 12-month target of $60 if growth continues.

timothysykes.com2 min
AUG 19
$HTFLMedAI 8/10

Why Heartflow Stock Soared Today

HeartFlow (HTFL) shares rose after the company raised its full-year revenue targets. Revenue grew 48% YoY to $64.1M in Q2, with adjusted gross margin increasing to 83.3%. The company now expects 40-42% revenue growth for 2026, up from prior forecasts. CEO John Farquhar cited improved operating leverage and scalability.

aol.com2 min